Michael Bishop - Telenav IR Contact Officer
Executive
Michael Bishop is IR Contact Officer of Telenav since 2018.
Tenure | 6 years |
Phone | 408 245-3800 |
Web | www.telenav.com |
Telenav Management Efficiency
The company has return on total asset (ROA) of (1.4) % which means that it has lost $1.4 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.36) %, meaning that it created substantial loss on money invested by shareholders. Telenav's management efficiency ratios could be used to measure how well Telenav manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 9.4 M in liabilities with Debt to Equity (D/E) ratio of 0.09, which may suggest the company is not taking enough advantage from borrowing. Telenav has a current ratio of 1.81, which is within standard range for the sector. Debt can assist Telenav until it has trouble settling it off, either with new capital or with free cash flow. So, Telenav's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Telenav sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Telenav to invest in growth at high rates of return. When we think about Telenav's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | EXECUTIVE Age | ||
Annette Such | Amgen Inc | 46 | |
Alan Russell | Amgen Inc | N/A | |
Sandra Frithiof | Calliditas Therapeutics | 49 | |
David MD | Amgen Inc | 61 | |
Mike Zahigian | Amgen Inc | N/A | |
Todd Anthony | Cumberland Pharmaceuticals | 63 | |
Sarah Comstock | Merit Medical Systems | N/A | |
Brian Lloyd | Merit Medical Systems | 63 | |
Chris Bitterman | Cumberland Pharmaceuticals | 59 | |
Hong Chen | HUTCHMED DRC | 54 | |
Tanya Zharov | Alvotech | 57 | |
Christina Siniscalchi | Alvotech | N/A | |
Brian Gorman | Calliditas Therapeutics | 48 | |
James MD | Amgen Inc | 52 | |
David Ng | HUTCHMED DRC | N/A | |
Patrick Eagan | Viemed Healthcare | 45 | |
John Hamm | Cumberland Pharmaceuticals | 68 | |
Richard MD | Calliditas Therapeutics | 60 | |
Giedrius Zunda | Alvotech | N/A | |
Qingmei Wang | HUTCHMED DRC | 61 | |
Teona Johnson | Calliditas Therapeutics | N/A |
Management Performance
Return On Equity | -6.36 | |||
Return On Asset | -1.4 |
Telenav Leadership Team
Elected by the shareholders, the Telenav's board of directors comprises two types of representatives: Telenav inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Telenav. The board's role is to monitor Telenav's management team and ensure that shareholders' interests are well served. Telenav's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Telenav's outside directors are responsible for providing unbiased perspectives on the board's policies.
Shawn Carolan, Independent Director | ||
Karen Francis, Independent Director | ||
Ken Xie, Independent Director | ||
Joseph Zaelit, Independent Director | ||
Richard Gold, Independent Director | ||
Lily Toy, General Counsel, Secretary | ||
Fuad Ahmad, Interim CFO, Principal Financial Officer and Principal Accounting Officer | ||
Loren Hillberg, General Counsel, Secretary and President of Thinknear and General Manager of Advter. Bus. Unit - Thinknear | ||
Hon Chiu, Independent Director | ||
Evan Berg, Vice President - Corporate Development and Strategy | ||
Philipp Kandal, Senior Vice President - Engineering | ||
Salman Dhanani, Co-Founder and Co-President of Automotive Bus. Unit | ||
Douglas Miller, Director | ||
Richard Todaro, Independent Director | ||
Michael Bishop, IR Contact Officer | ||
H Jin, Co-Founder, Chairman, CEO and Pres | ||
Michael Strambi, CFO and Treasurer | ||
Hassan Wahla, Co-President of Automotive Bus. Unit | ||
Adeel Manzoor, CFO | ||
Rohan Chandran, Vice President General Manager | ||
Randy Ortiz, Independent Director | ||
Wesley Cummins, Independent Director | ||
Samuel Chen, Independent Director |
Telenav Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Telenav a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -6.36 | |||
Return On Asset | -1.4 | |||
Profit Margin | (2.85) % | |||
Operating Margin | (2.97) % | |||
Current Valuation | 126.32 M | |||
Shares Outstanding | 48 M | |||
Shares Owned By Insiders | 37.13 % | |||
Shares Owned By Institutions | 49.30 % | |||
Number Of Shares Shorted | 397.12 K | |||
Price To Earning | 37.27 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Telenav in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Telenav's short interest history, or implied volatility extrapolated from Telenav options trading.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Telenav information on this page should be used as a complementary analysis to other Telenav's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Telenav Stock
If you are still planning to invest in Telenav check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Telenav's history and understand the potential risks before investing.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |